Dr. Milani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
17430 Crenshaw Blvd, Suite A Torrance, CA 90504
#260
Torrance, CA 90504Phone+1 424-435-1037
Summary
- Dr. Cannon Milani is an oncologist based in Torrance, CA, with specialized training from a fellowship in Hematology and Medical Oncology at Brown University following a residency in Internal Medicine at Roger Williams Medical Center. He has published several research articles, primarily focusing on plasmablastic lymphoma, and his works have been cited multiple times in other scholarly articles. Notably, he has participated in clinical trials, such as the Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma. In 2011, he received the Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services.
Education & Training
Brown UniversityFellowship, Hematology and Medical Oncology, 2007 - 2010
Roger Williams Medical CenterResidency, Internal Medicine, 2004 - 2007
Certifications & Licensure
CA State Medical License 2008 - 2026
ID State Medical License 2024 - 2025
OR State Medical License 2024 - 2025
NM State Medical License 2023 - 2024
RI State Medical License 2005 - 2010
DC State Medical License 2005 - 2006
American Board of Internal Medicine Hematology- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
Publications & Presentations
PubMed
- 72 citationsHIV-Negative Plasmablastic Lymphoma: Not in the MouthJorge J. Castillo, Eric S. Winer, Dariusz Stachurski, Kimberly Perez, Melhem Jabbour
Clinical Lymphoma, Myeloma & Leukemia. 2011-04-01 - 133 citationsClinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma.Jorge J. Castillo, Eric S. Winer, Dariusz Stachurski, Kimberly Perez, Melhem Jabbour
Leukemia & Lymphoma. 2010-11-15 - 95 citationsPrognostic Factors in Chemotherapy-Treated Patients with HIV-Associated Plasmablastic LymphomaJorge J. Castillo, Eric S. Winer, Dariusz Stachurski, Kimberly Perez, Melhem Jabbour
The Oncologist. 2010-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
